Literature DB >> 30792205

miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia.

Estrella Gonzales-Aloy1, Patrick Connerty1, Basit Salik1, Bing Liu2, Andrew J Woo3,4, Michelle Haber5, Murray D Norris5, Jianlong Wang6, Jenny Y Wang7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30792205      PMCID： PMC6601101          DOI： 10.3324/haematol.2018.209437

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

2.  Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia.

Authors:  J R Lynch; H Yi; D A Casolari; F Voli; E Gonzales-Aloy; T K Fung; B Liu; A Brown; T Liu; M Haber; M D Norris; I D Lewis; C W E So; R J D'Andrea; J Y Wang
Journal:  Leukemia       Date:  2016-02-09       Impact factor: 11.528

Review 3.  The role of miR-150 in normal and malignant hematopoiesis.

Authors:  Y He; X Jiang; J Chen
Journal:  Oncogene       Date:  2013-08-19       Impact factor: 9.867

4.  Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role.

Authors:  Takanori Sasaki; Hirotada Kojima; Rikiya Kishimoto; Ayu Ikeda; Hiroyuki Kunimoto; Koich Nakajima
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

Review 5.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

6.  The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

Authors:  Yingzi Wang; Andrei V Krivtsov; Amit U Sinha; Trista E North; Wolfram Goessling; Zhaohui Feng; Leonard I Zon; Scott A Armstrong
Journal:  Science       Date:  2010-03-26       Impact factor: 47.728

7.  Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.

Authors:  Satomi Tanaka; Satoru Miyagi; Goro Sashida; Tetsuhiro Chiba; Jin Yuan; Makiko Mochizuki-Kashio; Yutaka Suzuki; Sumio Sugano; Chiaki Nakaseko; Koutaro Yokote; Haruhiko Koseki; Atsushi Iwama
Journal:  Blood       Date:  2012-06-07       Impact factor: 22.113

8.  MicroRNA 29b functions in acute myeloid leukemia.

Authors:  Ramiro Garzon; Catherine E A Heaphy; Violaine Havelange; Muller Fabbri; Stefano Volinia; Twee Tsao; Nicola Zanesi; Steven M Kornblau; Guido Marcucci; George A Calin; Michael Andreeff; Carlo M Croce
Journal:  Blood       Date:  2009-10-22       Impact factor: 22.113

9.  Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.

Authors:  Sooryanarayana Varambally; Qi Cao; Ram-Shankar Mani; Sunita Shankar; Xiaosong Wang; Bushra Ateeq; Bharathi Laxman; Xuhong Cao; Xiaojun Jing; Kalpana Ramnarayanan; J Chad Brenner; Jindan Yu; Jung H Kim; Bo Han; Patrick Tan; Chandan Kumar-Sinha; Robert J Lonigro; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Science       Date:  2008-11-13       Impact factor: 47.728

10.  Exploring complex miRNA-mRNA interactions with Bayesian networks by splitting-averaging strategy.

Authors:  Bing Liu; Jiuyong Li; Anna Tsykin; Lin Liu; Arti B Gaur; Gregory J Goodall
Journal:  BMC Bioinformatics       Date:  2009-12-10       Impact factor: 3.169
View more
  3 in total

1.  Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.

Authors:  Yuu Saitoh; Tomohiro Umezu; Satoshi Imanishi; Michiyo Asano; Seiichiro Yoshizawa; Seiichiro Katagiri; Tamiko Suguro; Hiroaki Fujimoto; Daigo Akahane; Chiaki Kobayashi-Kawana; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

2.  Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia.

Authors:  Ming Tian; Wanjun Gong; Jingming Guo
Journal:  Biol Open       Date:  2019-10-18       Impact factor: 2.422

3.  Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma.

Authors:  Yangmao Tu; Qing Cai; Xuemei Zhu; Min Xu
Journal:  Braz J Med Biol Res       Date:  2021-01-08       Impact factor: 2.590
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.